Back to search

Article

Off-target prediction of SGLT2 inhibitors: an integrative bioinformatics approach to uncover structural mechanisms

2025-01-22

Abstract excerpt

Gliflozin is known to inhibit sodium glucose transporter 2 (SGLT2) inhibitors (SGLT2i). They have been approved for the treatments of diabetes mellitus, cardiovascular diseases, and chronic kidney disease in recent years. However, the mechanisms for the multifunction remain unclear. We here propose a hypothesis of other protein targets for gliflozins. Additionally, the multistage of the protein, the specificity of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45773401-d4ee-5f72-b7e4-8e55a66d712b
DOI
10.1101/2025.01.20.633821
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Off-target prediction of SGLT2 inhibitors: an integrative bioinformatics approach to uncover structural mechanismsDOI 10.1101/2025.01.20.633821
Select a neighboring publication to make it the new centre.